Department of Public Health Sciences, Clemson University, P.O. Box 340745, Clemson, SC, 29634-0745, USA.
Department of Nursing, Clemson University, Clemson, SC, USA.
Dig Dis Sci. 2018 Jun;63(6):1392-1408. doi: 10.1007/s10620-018-5054-z. Epub 2018 Apr 16.
Mobile applications and interactive websites are an increasingly used method of telemedicine, but their use lacks evidence in digestive diseases.
This study aims to explore digestive disease studies that use telemedicine to effectively manage disease activity, help monitor symptoms, improve compliance to the treatment protocol, increase patient satisfaction, and enhance the patient-to-provider communication.
EBSCO, PubMed, and Web of Science databases were searched using Medical Subject Headings and other keywords to identify studies that utilized telemedicine in patients with digestive disease. The PRISMA guidelines were used to identify 20 research articles that had data aligning with 4 common overlapping themes including, patient compliance (n = 13), patient satisfaction (n = 11), disease activity (n = 15), and quality of life (n = 13). The studies focused on digestive diseases including inflammatory bowel disease (n = 7), ulcerative colitis (n = 4), Crohn's Disease (n = 1), irritable bowel syndrome (n = 6), and colorectal cancer (n = 2).
From the studies included in this systematic review, patient compliance and patient satisfaction ranged between 25.7-100% and 74-100%, respectively. Disease activity, measured by symptom severity scales and physiological biomarkers, showed improvements following telemedicine interventions in several, but not all, studies. Similar to disease activity, general and disease-specific quality of life showed improvements following telemedicine interventions in as little as 12 weeks in some studies.
Telemedicine and mobile health technology may be effective in managing disease activity and improving quality of life in digestive diseases. Future studies should explore both gastrointestinal and gastroesophageal diseases using these types of interventions.
移动应用程序和交互式网站是远程医疗越来越常用的方法,但在消化疾病中使用这种方法的证据不足。
本研究旨在探讨使用远程医疗有效管理疾病活动、帮助监测症状、提高治疗方案依从性、提高患者满意度以及增强医患沟通的消化疾病研究。
使用医学主题词和其他关键字在 EBSCO、PubMed 和 Web of Science 数据库中进行搜索,以确定使用远程医疗治疗消化疾病患者的研究。使用 PRISMA 指南确定了 20 篇研究文章,这些文章的数据与 4 个常见重叠主题相符,包括患者依从性(n=13)、患者满意度(n=11)、疾病活动度(n=15)和生活质量(n=13)。这些研究主要关注消化疾病,包括炎症性肠病(n=7)、溃疡性结肠炎(n=4)、克罗恩病(n=1)、肠易激综合征(n=6)和结直肠癌(n=2)。
从本系统评价纳入的研究中,患者依从性和患者满意度分别为 25.7%-100%和 74%-100%。通过症状严重程度量表和生理生物标志物测量的疾病活动度,在几项研究中,远程医疗干预后有所改善,但并非所有研究都如此。与疾病活动度相似,在一些研究中,仅在 12 周内,一般和疾病特异性生活质量就随着远程医疗干预而改善。
远程医疗和移动健康技术可能在管理消化疾病的疾病活动度和提高生活质量方面有效。未来的研究应使用这些类型的干预措施来探索胃肠道和胃食管疾病。